Study Looking at a New Treatment for Pancreatic Cancer

What we are studying

The purpose of this study is to test the safety and effectiveness of an investigational drug when used to treat metastatic pancreatic cancer.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Must have metastatic pancreatic cancer

What is involved

  • The length of participation in this study will vary for each person and will be determined by the number of treatment cycles you receive.
  • All participants will be in the study for at least 9 weeks (which includes the preliminary 5 day course of treatment and the first 2 cycles of treatment).



Contact Information

Study Coordinator
Amy Neal

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.